Viewing nowCombinationRotimib Tablets 10/20 Milligrams
Ezetimibe 10mg · Rosuvastatin Calcium Micronized 20.8mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.

MFDS item code 201601198 · Approved 2016.02.29 · Insurance code 642003780
Improvement of primary hypercholesterolemia and mixed dyslipidemia
This medication helps to reduce total cholesterol, LDL-cholesterol, Apo B, triglycerides, and non-HDL-cholesterol while increasing HDL-cholesterol in patients with primary hypercholesterolemia, heterozygous familial and non-familial hypercholesterolemia, and mixed dyslipidemia. It is particularly recommended for use in conjunction with dietary therapy in patients at high risk for atherosclerotic vascular disease due to hypercholesterolemia. This medication is used when there is insufficient response to appropriate dietary modification and other non-pharmacological treatments, such as restrictions on saturated fat and cholesterol intake. Before administering this medication, any secondary causes of dyslipidemia, such as diabetes, hypothyroidism, liver disease, and renal failure, should be identified and treated if necessary. During treatment, total cholesterol, LDL, HDL, and triglyceride levels should be monitored periodically; particularly, if triglyceride levels are elevated, further testing may be required. This medication is used to improve blood lipid levels and lower the risk of cardiovascular disease.
This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dose range is 10/5mg to 10/20mg once daily. The recommended starting dose is 10/5mg once daily. For patients who require a greater reduction in LDL cholesterol, the dose may be adjusted. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose should be adjusted accordingly; it may be increased up to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
This medication can affect the muscles and, although rare, may cause a serious muscle disorder known as rhabdomyolysis. Patients with risk factors such as severe infections, hypotension, or surgical procedures should temporarily discontinue or stop using this medication. Patients with an allergy to the active ingredients or components of this medication, those with liver disease, muscle disorders, severe renal impairment, and women who are pregnant or breastfeeding should not be administered this medication. Additionally, careful use is recommended in cases where there is a history of muscle disease in the family, concurrent use with specific medications, or in patients with hypothyroidism, alcohol dependence, or those at high risk for myopathy. This medication contains lactose and is not suitable for patients with lactose intolerance or related genetic conditions. During administration, if symptoms relating to muscles such as myalgia, muscle weakness, or fever occur, it is important to notify a doctor immediately, and if needed, blood tests should be performed to check for muscle damage. Liver function abnormalities may occur, so liver function tests should be conducted before beginning treatment and during treatment; if liver enzyme levels rise, dosage adjustments or discontinuation should be considered. This medication may slightly increase blood glucose levels; however, its preventive effect against cardiovascular diseases is more significant, so patients requiring blood glucose management should regularly monitor their blood glucose levels. There could be interactions with other medications, so caution is needed, particularly when used in conjunction with anticoagulants, fibrates, certain antibiotics, and antifungals. Women who are pregnant or planning to become pregnant should consult a physician and use appropriate contraceptive methods, and breastfeeding women should avoid use. Safety and efficacy in children and the elderly have not been sufficiently established, so caution must be exercised in administration. In cases of overdose, there is no specific antidote, so treatment will be based on symptoms, and liver function and muscle enzyme levels should be regularly checked. This medication should be stored out of reach of children and should not be transferred to another container.
Acute renal failure due to myoglobinuria, rhabdomyolysis, nasopharyngitis, arthralgia, headache, elevated ALT, elevated AST, myalgia, edema, elevated serum bilirubin, acneiform dermatitis, pruritus, dizziness, upper respiratory infection, chest pain, facial edema, strange sensation, drug intolerance, colon polyps, irritable bowel syndrome, esophagitis, somnolence, neurodegenerative disorders, positional dizziness, migraine, diabetes, glucose load impairment, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver dysfunction, hepatic toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased alkaline phosphatase, irregular heartbeat, osteoarthritis, osteoporosis, musculoskeletal rigidity, musculoskeletal discomfort, muscle weakness, sweating, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cysts, eyelid ptosis, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, polyneuropathy, amnesia, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myopathy, rhabdomyolysis, fatigue, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, diabetic neuropathy, tremor, epigastric pain, vomiting, gastritis, xerostomia, epigastric discomfort, belching, gastrointestinal disorder, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinorrhea, limb pain, diabetes, hypoglycemia, anemia, splenomegaly, hyperhidrosis, conjunctival hyperemia, renal failure, abnormal liver function, increased serum creatinine, elevated blood pressure, increased blood urea, increased CPK, abnormal liver function test, anaphylaxis, erythema multiforme, cholelithiasis, cholecystitis, cholecystectomy, sexual dysfunction, gynecomastia, cognitive decline, forgetfulness, amnesic syndrome, memory impairment, confusion, myasthenia gravis.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain storage at room temperature, specifically between 1 to 30 degrees Celsius. This will help ensure that the medication's efficacy is preserved and it can be used safely.
Pink, oval film-coated tablets
30 tablets/box [10 tablets/PTP x 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEzetimibe 10mg · Rosuvastatin Calcium Micronized 20.8mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium Micronized 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication · Combination
Boryung Co., Ltd.
CombinationRosuvastatin Calcium Micronized 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium Micronized 20.8mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium Micronized 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.